You have 9 free searches left this month | for more free features.

TWINRIX™ ADULT

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatitis A, Hepatitis B Trial in Gent (Blood sampling, Engerix-B, Havrix)

Completed
  • Hepatitis A
  • Hepatitis B
  • Blood sampling
  • +2 more
  • Gent, Belgium
    GSK Investigational Site
Aug 31, 2018

Hepatitis A, Hepatitis B Trial in Wilrijk (Blood sampling, Engerix-B, Havrix)

Completed
  • Hepatitis A
  • Hepatitis B
  • Blood sampling
  • +2 more
  • Wilrijk, Belgium
    GSK Investigational Site
Aug 31, 2018

Hepatitis B, Hepatitis A Trial in Bruxelles, Hradec Kralove (Blood sampling, Additional challenge dose)

Completed
  • Hepatitis B
  • Hepatitis A
  • Blood sampling
  • Additional challenge dose
  • Bruxelles, Belgium
  • +1 more
Jul 18, 2018

HBV Immunity and HBV Vaccination in NAFLD in Canada

Completed
  • Non-Alcoholic Fatty Liver Disease
  • +2 more
  • Engerix-B
  • Calgary, Alberta, Canada
    University of Calgary
Nov 2, 2021

Blood Pressure Trial in Cloppenburg (Polso™ Watch blood pressure measurement compared to a reference blood pressure measurement)

Recruiting
  • Blood Pressure
  • Polso™ Watch blood pressure measurement compared to a reference blood pressure measurement
  • Cloppenburg, Low Saxony, Germany
    IPPMed - Institute for Pharmacology and Preventive Medicine GmbH
Feb 9, 2023

VIDAS® NEPHROCLEAR Reference Interval Study

Active, not recruiting
  • Healthy
  • Diagnostic Test: VIDAS® NEPHROCLEAR™ CCL14 Test
  • Washington, District of Columbia
  • +1 more
Sep 7, 2023

Relative Bioavailability Trial (PanCytoVir™ 100 mg/mL oral suspension, Probenecid 500 mg)

Not yet recruiting
  • Relative Bioavailability
  • PanCytoVir™ 100 mg/mL oral suspension
  • Probenecid 500 mg
  • (no location specified)
Sep 5, 2023

Short- and Medium-term Evaluation of Mastoid Filling Using

Not yet recruiting
  • Cholesteatoma
  • verre bioactif 45S5 GlassBONE
  • verre bioactif S53P4 Bonalive
  • Lyon, Pierre-Bénite, France
    Hôpital Lyon Sud
Jun 16, 2023

Atopic Dermatitis Trial in Kotara (BioLexa- Cohort 1, BioLexa- Cohort 2, Placebo)

Completed
  • Atopic Dermatitis
  • BioLexa- Cohort 1
  • +3 more
  • Kotara, New South Wales, Australia
    Novatrials
Nov 14, 2022

Type 1 Diabetes Trial in United States (MiniMed 780G System)

Recruiting
  • Type 1 Diabetes
  • MiniMed 780G System
  • Palo Alto, California
  • +16 more
Jan 24, 2023

PRO-CTCAE for Adult-type Diffuse Gliomas Chinese Population

Not yet recruiting
  • Glioma
  • +3 more
    • Beijing, Beijing, China
    • +16 more
    Aug 4, 2022

    Diabetes Type 1 Trial in Rotterdam, Örebro (InPen with Guardian 4 System)

    Not yet recruiting
    • Diabetes Type 1
    • InPen with Guardian 4 System
    • Rotterdam, Netherlands
    • +1 more
    May 18, 2022

    Crohn's Disease Trial in United States (CDPATH™, Blood Draw)

    Recruiting
    • Crohn's Disease
    • CDPATH™
    • Blood Draw
    • Phoenix, Arizona
    • +54 more
    Nov 10, 2022

    Medication Adherence Trial in Izmir (Behavioral: SystemCHANGE, Education)

    Completed
    • Medication Adherence
    • Behavioral: SystemCHANGE
    • Education
    • İzmir, Turkey
      Yaprak Sarıgöl Ordin
    Oct 24, 2023

    Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • +4 more
    • CTX131
    • Nashville, Tennessee
      Research Site 1
    Mar 21, 2023

    Heart Failure, Acute Decompensated Heart Failure Trial in Evanston (Impella BTR)

    Recruiting
    • Heart Failure
    • Acute Decompensated Heart Failure
    • Impella BTR
    • Evanston, Illinois
      Northwestern University
    May 23, 2022

    ImmuneSense™ IBD Study

    Recruiting
    • Inflammatory Bowel Diseases
      • Hialeah, Florida
      • +5 more
      Mar 3, 2023

      Heart Failure Trial in Frankfurt, Florence (V-LAP™ System)

      Active, not recruiting
      • Heart Failure
      • V-LAP™ System
      • Frankfurt, Germany
      • +1 more
      Jul 12, 2022

      Cellulite Trial in New York (Collagenase Clostridium Histolyticum-Aaes, Lysteda 650 MG Oral Tablet)

      Recruiting
      • Cellulite
      • Collagenase Clostridium Histolyticum-Aaes
      • Lysteda 650 MG Oral Tablet
      • New York, New York
        Luxurgery
      Aug 15, 2022

      COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))

      Not yet recruiting
      • COVID-19
      • XBB.1.5 Vaccine (Booster)
      • XBB.1.5 Vaccine (single dose)
      • Mobile, Alabama
      • +29 more
      Aug 4, 2023

      Helicobacter Pylori Infection Trial in Israel, United States (Dual Mode BreathID Hp System)

      Completed
      • Helicobacter Pylori Infection
      • Dual Mode BreathID Hp System
      • Tucson, Arizona
      • +12 more
      Dec 19, 2022

      Hepatitis B, Hepatitis A Trial in Wilrijk (TWINRIX™ ADULT, Engerix TM)

      Completed
      • Hepatitis B
      • Hepatitis A
      • TWINRIX™ ADULT
      • Engerix TM
      • Wilrijk, Belgium
        GSK Investigational Site
      Jul 19, 2018

      Type 1 Diabetes Trial in United States (Insulin Pump with Continuous Glucose Monitoring)

      Not yet recruiting
      • Type 1 Diabetes
      • Insulin Pump with Continuous Glucose Monitoring
      • Little Rock, Arkansas
      • +20 more
      Feb 3, 2023

      Wound Healing, Diabetic Foot, Chronic Foot Ulcer Trial in Hollywood, Salem (Endoform™ Antibacterial, Endoform™ Natural,

      Recruiting
      • Wound Healing
      • +3 more
      • Endoform™ Antibacterial
      • +2 more
      • Hollywood, Florida
      • +1 more
      Sep 13, 2023

      Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Trial in Jordan, Kenya, Lebanon (INO-4700, Placebo, CELLECTRA™ 2000)

      Completed
      • Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
      • Irbid, Jordan
      • +5 more
      Jan 27, 2023